Our quantitative proteomic strategy allowed the identification of five potential biomarkers of AAA, three of which are proteins involved in the regulation of the kallikrein-kinin system, which others have suggested may play a role in the evolution of AAA. This evidence concerns the gene KLK4 and triple-A syndrome.